Sarah Cork
Subscribe to all posts by Sarah Cork
“Orphan” drug exclusivity, which is intended to reward drug companies’ investment in the development of certain drugs, might soon be harder to get—and keep. Over the past several months, Congress introduced two similar bills to amend a “loophole” in the Orphan Drug Act (ODA). On October 17, 2019, a bipartisan group of House members introduced … Continue Reading
Bipartisan Congress Intensifies Efforts to Restrict Orphan Drug Exclusivity
By Sarah Cork on Posted in Federal Rules, Life Sciences
